Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors

被引：30

作者：

Wu, Kui ^{[1
]}

Ai, Jing ^{[2
]}

Liu, Qiufeng ^{[3
]}

Chen, TianTian ^{[3
]}

Zhao, Ailing ^{[4
]}

Peng, Xia ^{[2
]}

Wang, Yuanxiang ^{[4
]}

Ji, Yinchun ^{[2
]}

Yao, Qizheng ^{[1
]}

Xu, Yechun ^{[3
]}

Geng, Meiyu ^{[2
]}

Zhang, Ao ^{[4
]}

机构：

[1] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China

[3] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China

[4] Chinese Acad Sci, Shanghai Inst Mat Med, Synthet Organ & Med Chem Lab, Shanghai 201203, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 20期

基金：

中国国家自然科学基金; 美国国家科学基金会;

关键词：

c-Met kinase; 3,5-Diamino-7-trifluoroquinoline; hERG; Antitumor activity; Structure-activity relationship (SAR); SCATTER-FACTOR; GROWTH; METASTASIS; POTENT;

D O I：

10.1016/j.bmcl.2012.08.075

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Two series of new analogues were designed by replacing the quinoline scaffold of our earlier lead 2 (zgw-atinib) with quinoxaline and pyrido[2,3-d]pyrimidine frameworks. Moderate c-Met inhibitory activity was observed in the quinoxaline series. Among the pyrido[2,3-d]pyrimidine series, compounds 13a-c possessing an O-linkage were inactive, whilst the N-linked analogues 15a-c retained c-Met inhibitory potency. Highest activity was observed in the 3-nitrobenzyl analog 15b that showed an IC50 value of 6.5 nM. Further structural modifications based on this compound were undergoing. (c) 2012 Elsevier Ltd. All rights reserved.

引用

页码：6368 / 6372

页数：5

共 50 条

[21] The synthesis and SAR of 2-anilinopyrido[2,3-d]pryrimidines as potent tyrosine kinase inhibitors.
Schroeder, MC
Eummer, JT
Showalter, HDH
Panek, RL
Lu, GH
Batley, BL
Dahring, TK
Kraker, AJ
Moore, CW
Hartl, BG
Klohs, WD
Steinkampf, RD
Doherty, AM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 199 - MEDI
[22] Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
Metwally, Kamel
Abo-Dya, Nader E.
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (36) : 5918 - 5936
[23] Pyrido[2,3-d]pyrimidines and their ribofuranosides:: Synthesis and antimicrobial investigations
Kumar, Naresh
Tiwari, Sangeeta
Yadav, Ashok K.
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2007, 46 (04): : 702 - 706
[24] Pyrido [2,3-d] pyrimidines and their ribofuranosides:: Synthesis and antimicrobial evaluations
Khatoon, S
Kumar, N
Yadav, AK
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2004, 13 (04) : 331 - 334
[25] Synthesis of novel condensed pyridines and pyrido[2,3-d]pyrimidines
E. G. Paronikyan
A. S. Noravyan
A. S. Harutunyan
Chemistry of Heterocyclic Compounds, 2010, 46 : 987 - 990
[26] SYNTHESIS OF PYRIDO[2,3-D]PYRIMIDINES CONDENSED WITH TETRAHYDROPYRAN AND TETRAHYDROTHIOPYRAN
PARONIKYAN, EG
SIRAKANYAN, SN
NORAVYAN, AS
KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1993, (12): : 1683 - 1687
[27] SYNTHESIS OF HETEROCYCLES .4. PYRIDO[2,3-D]-PYRIMIDINES
RAO, AS
MITRA, RB
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1981, 20 (02): : 159 - 160
[28] SYNTHESIS OF PYRIDO[2,3-D]PYRIMIDINES WITH TRIMETHOPRIM PARTIAL STRUCTURE
TROSCHUTZ, R
ARCHIV DER PHARMAZIE, 1989, 322 (05) : 285 - 290
[29] A new and highly expedient synthesis of pyrido[2,3-d]pyrimidines
Bagley, MC
Hughes, DD
Lloyd, R
Powers, VEC
TETRAHEDRON LETTERS, 2001, 42 (37) : 6585 - 6588
[30] Synthesis of nucleosides of pyrido[2,3-d]pyrimidines and their microbial activity
Singh, G
Swati
Mishra, AK
Prakash, L
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1998, 37 (05): : 517 - 520

← 1 2 3 4 5 →